Back to results
US 8,772,464 B2Granted
Aptamer regulated nucleic acids and uses thereof
AssigneeCalifornia Institute of Technology
InventorsChristina D. Smolke, Travis S. Bayer
Life of this patent
Estimating the term…
Abstract
The invention relates to aptamer-regulated, ligand-responsive nucleic acids, or “ampliSwitches,” and uses thereof. Particular embodiments include a ligand-responsive nucleic acid that comprises a primer sequence domain and an aptamer domain that is responsive to a ligand.
Claims18
A nucleic acid comprising:
- (i) an aptamer comprising a 5′-end switching aptamer stem sequence;
- and
- (ii) a 3′-end priming sequence;
- wherein:
- (1) in a first conformation, the 3′-end priming sequence forms a hairpin structure, and the 5′-end switching aptamer stem sequence is single-stranded;
- and,
- (2) in a second conformation, the 5′-end switching aptamer stem sequence hybridizes to a complementary region of the nucleic acid, and the 3′-end priming sequence is available for hybridization to a target template to form a primer:template pair;
- wherein binding to a ligand by the aptamer induces a conformational change of the nucleic acid to shift between the first conformation and the second conformation, or between the second conformation and the first conformation.
5 more elements
Dependencies are inferred from the claim text.